Humana

Why Every Pharmacist Should Care About the CVS/Aetna Deal
Why Every Pharmacist Should Care About the CVS/Aetna DealEven if it doesn't happen, the deal says a lot about the current and future states of pharmacy.
Potential CVS-Aetna merger: Key takeaways for health execsThe CVS Health-Aetna potential merger will have healthcare executives rethinking traditional industry competitors. Here’s why.
Three things you may not know about arthritisA study from Humana and the CDC sheds eye-opening results about arthritis and health-related quality of life.
Controversy surrounds Exondys 51 approval: What to knowNew medicine for Duchenne muscular dystrophy raises questions. Here’s whose covering it and why.
Three reasons for nonadherenceUncover the root causes of why patients become nonadherent and be better positioned to improve the lives of patients and reduce costs through improved health outcomes.
ACA exchanges: Who's in, who's out?What MCOs should know about insurers’ plans for the marketplace exchanges in 2018.
Humana shares its population health management secretsHumana’s goal is to improve the health of the communities it serves 20% by the year 2020. Find out how it is reaching this goal.
One plan’s unique approach to combat diabetes, obesityThis novel approach aims to help those already struggling with obesity and diabetes, but eventually win the fight against this epidemic.
Pharmacists Pushing for DIR Relief
Pharmacists Pushing for DIR ReliefCommunity pharmacists fight against financial pressure for their survival.
Healthcare mergers and acquisitions: What payers, providers will do in 2017Integrating businesses is complex, but experts shed light on other options including partnerships and shared services.